The omnibus budget deal approved by House and Senate appropriations committees last week only partially restores biomedical research funds cut by the sequestration.
Cholesterol Levels Linked to Alzheimer’s Brain Plaques
January 17, 2014 | by
Study Identifies Skin Biomarker for Parkinson’s Disease
November 7, 2013 | by
Researchers from Beth Israel Deaconess Medical Center (BIDMC) report in the October 29th issue of the journal Neurology that elevated levels of the protein alpha-synuclein can be detected in the skin of Parkinson’s disease patients [1]. The finding offers a potential biomarker to enable doctors to identify and diagnose Parkinson’s before the disease has reached an advanced stage.
Study Suggests Sleep Detoxes the Brain
October 24, 2013 | by
A good night’s rest may literally clear the mind. Using mice, researchers showed for the first time that the space between brain cells may increase during sleep, allowing the brain to flush out toxins that build up during waking hours. These results suggest a new role for sleep in health and disease. The study was funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the NIH.
Biomarker Bulletin: September 23, 2013
September 23, 2013 | by
Biomarker Bulletin is an occasionally recurring update of news focused on biomarkers aggregated at BiomarkerCommons.org. Biomarkers are physical, functional or biochemical indicators of normal physiological or disease processes. The individualization of disease management — personalized medicine — is dependent on developing biomarkers that promote specific clinical domains, including early detection, risk, diagnosis, prognosis and predicted response to therapy.
